Bank Of New York Mellon Corp Ionis Pharmaceuticals Inc Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$33.58 - $41.2 $19 Million - $23.3 Million	566,095 New	566,095 $20.2 Billion
Q4 2022 Feb 14, 2023	BUY	$37.12 - $46.52 $21.3 Million - $26.7 Million	573,798 New	573,798 $21.7 Million
Q3 2022 Nov 14, 2022	SELL	$36.54 - $48.66 $3.14 Million - $4.18 Million	-85,903 Reduced 12.91%	579,413 $25.6 Million
Q2 2022 Aug 15, 2022	BUY	$31.71 - $43.0 $3.68 Million - $4.99 Million	116,069 Added 21.13%	665,316 $24.6 Million
Q1 2022 May 11, 2022	SELL	$29.88 - $37.04 $219,020 - $271,503	-7,330 Reduced 1.32%	549,247 $20.3 Million
Q4 2021 Feb 11, 2022	SELL	$25.61 - $35.1 $102,158 - $140,013	-3,989 Reduced 0.71%	556,577 $16.9 Million
Q3 2021 Nov 12, 2021	BUY	$33.54 - $40.55 $672,040 - $812,500	20,037 Added 3.71%	560,566 $18.8 Million
Q2 2021 Aug 11, 2021	SELL	$34.54 - $47.25 $157,813 - $215,885	-4,569 Reduced 0.84%	540,529 $21.6 Million
Q1 2021 May 13, 2021	SELL	$42.51 - $63.78 $1.06 Million - $1.59 Million	-24,896 Reduced 4.37%	545,098 $24.5 Million
Q4 2020 Feb 09, 2021	BUY	$45.3 - $60.27 $1.03 Million - $1.36 Million	22,638 Added 4.14%	569,994 $32.2 Million
Q3 2020 Nov 12, 2020	SELL	$47.45 - $62.95 $365,602 - $485,029	-7,705 Reduced 1.39%	547,356 $26 Million
Q2 2020 Aug 12, 2020	BUY	$46.85 - $61.05 $51,113 - $66,605	1,091 Added 0.2%	555,061 $32.7 Million
Q1 2020 May 06, 2020	SELL	$41.6 - $63.4 $823,846 - $1.26 Million	-19,804 Reduced 3.45%	553,970 $26.2 Million
Q4 2019 Feb 14, 2020	BUY	$53.85 - $65.27 $1.43 Million - $1.73 Million	26,539 Added 4.85%	573,774 $34.7 Million
Q3 2019 Nov 07, 2019	BUY	$59.06 - $72.15 $106,308 - $129,870	1,800 Added 0.33%	547,235 $32.8 Million
Q2 2019 Aug 12, 2019	BUY	$62.09 - $86.14 $1.64 Million - $2.27 Million	26,378 Added 5.08%	545,435 $35.1 Million
Q1 2019 May 14, 2019	SELL	$52.92 - $81.17 $594,027 - $911,133	-11,225 Reduced 2.12%	519,057 $42.1 Million
Q4 2018 Feb 11, 2019	BUY	$43.37 - $59.54 $103,220 - $141,705	2,380 Added 0.45%	530,282 $28.7 Million
Q3 2018 Nov 09, 2018	BUY	$42.88 - $53.7 $374,814 - $469,391	8,741 Added 1.68%	527,902 $0
Q2 2018 Aug 06, 2018	SELL	$40.53 - $50.7 $935,675 - $1.17 Million	-23,086 Reduced 4.26%	519,161 $21.6 Million
Q1 2018 May 15, 2018	BUY	$44.08 - $55.05 $60,389 - $75,418	1,370 Added 0.25%	542,247 $23.9 Million
Q4 2017 Feb 09, 2018	BUY	$50.3 - $64.39 $27.2 Million - $34.8 Million	540,877	540,877 $27.2 Million

Others Institutions Holding IONS

# of Institutions

403

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

Vanguard Group Inc Valley Forge, PA

15.1M
Shares

$567 Million
0.01% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

14.2M
Shares

$534 Million
0.34% of portfolio
Black Rock Inc. New York, NY

10.3M
Shares

$389 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

8.74M
Shares

$329 Million
0.06% of portfolio
Bellevue Group Ag Kuesnacht, V8

7.87M
Shares

$297 Million
5.32% of portfolio

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account